{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:52:20Z","timestamp":1792043540030,"version":"4.4.0"},"reference-count":70,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2013,11,18]],"date-time":"2013-11-18T00:00:00Z","timestamp":1384732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0080639","type":"journal-article","created":{"date-parts":[[2013,11,19]],"date-time":"2013-11-19T03:29:48Z","timestamp":1384831788000},"page":"e80639","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Cost-Effectiveness Analysis of the Bivalent and Quadrivalent Human Papillomavirus Vaccines from a Societal Perspective in Colombia"],"prefix":"10.1371","volume":"8","author":[{"given":"Johanna","family":"Aponte-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Fajardo-Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Eslava-Schmalbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Gamboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel W.","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,11,18]]},"reference":[{"key":"ref1","article-title":"Todo sobre el C\u00e1ncer de Cuello Uterino. Informaci\u00f3n Institucional"},{"key":"ref2","article-title":"Tabla 1. Distribuci\u00f3n de casos nuevos de c\u00e1ncer por sexo, seg\u00fan lcalizaci\u00f3n primaria, INC, Colombia","year":"2009"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer","volume":"55","author":"FX Bosch","year":"2002","journal-title":"J Clin Pathol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1469-0691.2008.02120.x","article-title":"Prevalence of infection with high-risk human papillomavirus in women in Colombia","volume":"15","author":"SC Soto-De Leon","year":"2009","journal-title":"Clin Microbiol Infect France"},{"key":"ref5","author":"Mundial de la Salud"},{"key":"ref6","first-page":"107","article-title":"[Quality of vaginal smear for cervical cancer screening: a concordance study]","volume":"30","author":"R Cendales","year":"2010","journal-title":"Biomedica"},{"key":"ref7","article-title":"Detecci\u00f3n Temprana de C\u00e1cncer de Cuello Uterino y de Mama","year":"2010"},{"key":"ref8","first-page":"467","article-title":"[Cervical cancer control in Colombia: achievements and challenges of cytology based programs]","volume":"28","author":"R Murillo","year":"2008","journal-title":"Biomedica"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3201\/eid1301.060438","article-title":"Model for assessing human papillomavirus vaccination strategies","volume":"13","author":"EH Elbasha","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"F16","DOI":"10.1016\/j.vaccine.2008.02.040","article-title":"Comparison of detailed and succinct cohort modelling approaches in a multi-regional evaluation of cervical cancer vaccination","volume":"26","author":"D Debicki","year":"2008","journal-title":"Vaccine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/jnci\/djh104","article-title":"Projected clinical benefits and cost-effectiveness of a human papillomavirus 16\/18 vaccine","volume":"96","author":"SJ Goldie","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/oxfordjournals.aje.a010166","article-title":"Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis","volume":"151","author":"ER Myers","year":"2000","journal-title":"Am J Epidemiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1590\/S0036-36342008000400005","article-title":"Cost-effectiveness of conventional cytology and HPV DNA testing for cervical cancer screening in Colombia","volume":"50","author":"O Andr\u00e9s-Gamboa","year":"2008","journal-title":"Salud Publica Mex"},{"key":"ref14","article-title":"\u2014\u2014General de Promoci\u00f3n y Prevenci\u00f3n Direcci\u00f3n NORMA T\u00c9CNICA PARA LA DETECCI\u00d3N TEMPRANA DEL C\u00c1NCER DE CUELLO UTERINO Y GU\u00cdA DE ATENCI\u00d3N DE LESIONES PRENEOPL\u00c1SICAS DE CUELLO UTERINO","author":"de Salud"},{"key":"ref15","article-title":"Making Choises in Health. WHO guide to cost-effectiveness analysis","author":"T Tan-Torres","year":"2003"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1086\/425907","article-title":"Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results","author":"N Munoz","year":"2004","journal-title":"J Infect Dis United States"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/aje\/kwg171","article-title":"Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study","volume":"158","author":"M Molano","year":"2003","journal-title":"Am J Epidemiol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7705\/biomedica.v29i3.2","article-title":"Supervivencia de pacientes con c\u00e1ncer de cuello uterino tratadas en el Instituto Nacional de Cancerolog\u00eda","volume":"29","author":"C Pardo","year":"2009","journal-title":"Biomedica"},{"key":"ref19","article-title":"HPV Infection Causality for LSIL, HSIL and Cervical","author":"M Molano","year":"2012","journal-title":"Cancer"},{"key":"ref20","article-title":"\u2014\u2014Rep\u00fablica de Colombia Website Coberturas de Vacunaci\u00f3n Departamental de 1994 a 2010","author":"de la Protecci\u00f3n Social"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(09)61567-1","article-title":"Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years","volume":"374","author":"B Romanowski","year":"2009","journal-title":"Lancet"},{"key":"ref22","first-page":"1949","article-title":"Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial. Lancet. England","author":"N Munoz","year":"2009"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"a769","DOI":"10.1136\/bmj.a769","article-title":"Economic evaluation of human papillomavirus vaccination in the United Kingdom","volume":"337","author":"M Jit","year":"2008","journal-title":"BMJ"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"d5775","DOI":"10.1136\/bmj.d5775","article-title":"Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model","volume":"343","author":"M Jit","year":"2011","journal-title":"BMJ"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurpub\/ckp141","article-title":"A cost-utility analysis of adding a bivalent or quadrivalent HPV vaccine to the Irish cervical screening programme","volume":"20","author":"A Dee","year":"2010","journal-title":"Eur J Public Health"},{"key":"ref26","first-page":"2161","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet. England","author":"J Paavonen","year":"2007"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1016\/j.vaccine.2010.07.007","article-title":"Sustained efficacy and immunogenicity of the HPV-16\/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women","volume":"28","author":"N De Carvalho","year":"2010","journal-title":"Vaccine"},{"key":"ref28","first-page":"271","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. England","author":"LL Villa","year":"2005"},{"key":"ref29","first-page":"001318","article-title":"Surgery for cervical intraepithelial neoplasia","author":"PP Martin-Hirsch","year":"2010","journal-title":"Cochrane Database Syst Rev CD"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0020-7292(99)00162-9","article-title":"Treatment outcomes for squamous intraepithelial lesions","volume":"68","author":"J Nuovo","year":"2000","journal-title":"Int J Gynecol Obstet"},{"key":"ref31"},{"key":"ref32","article-title":"Ministerio de la Proteccion Social Rep\u00fablica de Colombia, Centro de Estudios e Investigacion en Salud de la Fundacion Santa Fe de Bogota","year":"2010"},{"key":"ref33","article-title":"CON C\u00c1NCER. Bogot\u00e1, Colombia"},{"key":"ref34","first-page":"2423","article-title":"31 DE DICIEMBRE DE 1996 Manual Tarifario.","author":"de la Rep\u00fablica de","year":"1996"},{"key":"ref35","article-title":"Circular 2 de 2010"},{"key":"ref36","first-page":"2008","article-title":"INGRESO LABORAL","year":"2011"},{"key":"ref37","year":"2006"},{"key":"ref38","article-title":"Ministerio de Transporte Rep\u00fablica de Colombia","volume":"9900","year":"2002","journal-title":"Resoluci\u00f3n"},{"key":"ref39","article-title":"Ministerio de la Protecci\u00f3n Social - Consejo Nacional de Seguridad Social en Salud","year":"2006"},{"key":"ref40","article-title":"COST-EFFECTINENESS in HEALTH and MEDICINE","author":"M Gold","year":"1996"},{"key":"ref41","article-title":"_COLOMBIA Website; Poblacional de Cancer de Registro Colombia"},{"key":"ref42","article-title":"Designing and Conducting Cost-Effectiveness Analyses in Medicine and Health Care","author":"P Muennig","year":"2002"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.18597\/rcog.238","article-title":"Interpretaci\u00f3n de estudios de costo-efectividad en ginecolog\u00eda Interpreting cost-effectiveness analysis studies in gynecology","volume":"62","author":"J Aponte-Gonz\u00e1lez","year":"2011","journal-title":"Rev Colomb Obstet Ginecol"},{"key":"ref44","article-title":"Website WHO-CHOICE. <italic>CHO<\/italic>osing <italic>I<\/italic>nterventions that are <italic>C<\/italic>ost <italic>E<\/italic>ffective"},{"key":"ref45","article-title":"World Development Indicators database World Bank","year":"2006"},{"key":"ref46","article-title":"Website","year":"2010","journal-title":"Population"},{"key":"ref47","first-page":"15","article-title":"The Value of Vaccination","volume":"6","author":"DE Bloom","year":"2005","journal-title":"World Econ"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.vaccine.2012.01.031","article-title":"Cost-effectiveness of pneumococcal conjugate vaccines of 7, 10, and 13 valences in Colombian children","volume":"30","author":"C Casta\u00f1eda-Orjuela","year":"2012","journal-title":"Vaccine"},{"key":"ref49","first-page":"209","article-title":"[Epidemiological and economic impact of tetanus vaccination in Colombian adults]","volume":"30","author":"N Alvis","year":"2011","journal-title":"Rev Panam Salud Publica"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.1016\/j.vaccine.2011.08.006","article-title":"Cost-effectiveness of the introduction of the pneumococcal polysaccharide vaccine in elderly Colombian population","volume":"29","author":"C Casta\u00f1eda-Orjuela","year":"2011","journal-title":"Vaccine"},{"key":"ref51","article-title":"[Evaluating the burden of disease caused by human papillomavirus in Bogota]","author":"F de la Hoz-Restrepo","year":"2009","journal-title":"Rev Salud Publica"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"L59","DOI":"10.1016\/j.vaccine.2008.05.063","article-title":"Mathematical Models of Cervical Cancer Prevention in Latin America and the Caribbean","volume":"26","author":"SJ Goldie","year":"2008","journal-title":"Vaccine"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1016\/j.vaccine.2007.04.086","article-title":"The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada","volume":"25","author":"M Brisson","year":"2007","journal-title":"Vaccine"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3201\/eid1402.070499","article-title":"Cost-effectiveness of human papillomavirus vaccination in the United States","volume":"14","author":"HW Chesson","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1016\/j.vaccine.2009.06.097","article-title":"Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries","volume":"27","author":"L Colantonio","year":"2009","journal-title":"Vaccine"},{"key":"ref56","article-title":"[Following-up females having an abnormal Pap smear in Colombia]","author":"C Wiesner","year":"2010","journal-title":"Rev Salud Publica"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3201\/eid0901.020168","article-title":"Cost-effectiveness of a potential vaccine for human papillomavirus","volume":"9","author":"GD Sanders","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"ref58","article-title":"Social Rep\u00fablica de Colombia Website. Perfil Epidemiol\u00f3gico del VIH\/Sida en Colombia 2012","author":"de la Protecci\u00f3n"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/COH.0b013e328319bcbe","article-title":"Prevention of cervical cancer in women with HIV","volume":"4","author":"I Heard","year":"2009","journal-title":"Curr Opin HIV Aids"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/OGX.0b013e3182732375","article-title":"Cervical cancer screening in high- and low-resource countries: implications and new developments","volume":"67","author":"C Hoppenot","year":"2012","journal-title":"Obstet Gynecol Surv"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1471-2458-11-203","article-title":"Cost-effectiveness of different human papillomavirus vaccines in Singapore","volume":"11","author":"VJ Lee","year":"2011","journal-title":"BMC Public Health"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1471-2334-9-119","article-title":"Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model","volume":"9","author":"RP Insinga","year":"2009","journal-title":"BMC Infect Dis"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.1016\/j.vaccine.2007.05.058","article-title":"Cost-effectiveness of HPV 16, 18 vaccination in Brazil","volume":"25","author":"SJ Goldie","year":"2007","journal-title":"Vaccine"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ygyno.2008.09.031","article-title":"Health and economic impact associated with a quadrivalent HPV vaccine in Italy","volume":"112","author":"FS Mennini","year":"2009","journal-title":"Gynecol Oncol"},{"key":"ref65","first-page":"301","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. England","author":"J Paavonen","year":"2009"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/597307","article-title":"The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years","volume":"199","author":"DR Brown","year":"2009","journal-title":"J Infect Dis"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-132-10-200005160-00009","article-title":"Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review","volume":"132","author":"K Nanda","year":"2000","journal-title":"Ann Intern Med"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.AOG.0000296488.85807.b3","article-title":"Liquid compared with conventional cervical cytology: a systematic review and meta-analysis","volume":"111","author":"M Arbyn","year":"2008","journal-title":"Obstet Gynecol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4067\/S0717-75262006000300007","article-title":"Validaci\u00f3n de la Citologia C\u00e9rvico Uterina Convencional con Prueba de Referencia Histopatol\u00f3gica en la Identificaci\u00f3n de C\u00e1ncer Escamocelular Invasor","volume":"71","author":"E Garc\u00eda","year":"2006","journal-title":"Rev Chil Obstet Ginecol"},{"key":"ref70","article-title":"Wesite. Metrics: Disability-Adjusted Life Year (DALY)"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0080639","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T11:54:22Z","timestamp":1596887662000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0080639"}},"subtitle":[],"editor":[{"given":"Shannon\u00a0M.","family":"Hawkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,18]]},"references-count":70,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0080639","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,18]]}}}